Pharma Industry News

October 11 2024 – Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data

Written by David Miller

Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data
Teva hands over $450M to resolve kickback lawsuits involving MS drug Copaxone and generics
Roche gets FDA green light for breast cancer drug Itovebi
Sanofi in talks to sell stake in consumer health spinout
*please scroll down for all the latest news*

Check open job listings in your area

Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud
*please scroll down for all the latest news* image: Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

Leave a Comment

[mwai_chat window="true" fullscreen="true"]